Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
113NH3 PET/CT scan----[1] 84
218FDG PET/CT scan----[1] 84
368Ga-DOTA-TATE PET/MR and PET/CT imaging[1] Dotatate---[1] 238
468Ga-DOTATATE PET/CT[2] Dotatate,
Dotatate gallium Ga-68		---[1] 84
5[18F]-FLT-PET/CT scans----[1] 34
6[18F]FDOPA PET/CT----[1] 6
7Combination Product: 68Ga-DOTATATE PET/CT[2] Dotatate,
Dotatate gallium Ga-68		---[1] 238
8Diagnostic Test: 18F-FDG and 68Ga-FAPI PET/CT[1] Fludeoxyglucose (18F)---[1] 96
9Diagnostic Test: 68-Ga HA-DOTATATE PET/CT[1] Dotatate---[1] 41
10Diagnostic Test: 68Ga-DOTA-TOC PET/CT----[1] 84
11Diagnostic Test: FDG-PET/CT with Rb82 Myocardial Perfusion Imaging----[1] 84
12MRI, FDG-PET/CT scans----[1] 34
13Other: 18F-FDG PET/CT[1] Fludeoxyglucose (18F)---[1] 41
14Other: 18F-Fluorodeoxyglucose (18F-FDG) PET/CT[1] Fludeoxyglucose (18F)---[1] 84
15PET/CT----[1] 6
16PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714----[1] 85
17Radiation: 11C-MET PET/CT Imaging----[1] 53
18Radiation: 18F-FDG PET/CT Imaging[1] Fludeoxyglucose (18F)---[1] 53
19Radiation: PET/CT Scan----[1] 67
20Radiation: PET/CT Scan: Two PET scans using 1. C-11 HED and 2. N-13 Ammonia or rubidium-82[2] Ammonia,
Rubidium		[1] D02916 --[1] 86